---
title: 'An evaluation of the National Institutes of Health grants portfolio: identifying
  opportunities and challenges for multi-omics research that leverage metabolomics
  data'
date: '2022-04-30'
linkTitle: http://link.springer.com/10.1007/s11306-022-01878-8
source: Latest Results for Metabolomics
description: ' <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section
  id-a-sec1"> <h3 class="a-plus-plus">Background</h3> <p class="a-plus-plus">Through
  the systematic large-scale profiling of metabolites, metabolomics provides a tool
  for biomarker discovery and improving disease monitoring, diagnosis, prognosis,
  and treatment response, as well as for delineating disease mechanisms and etiology.
  As a downstream product of the genome and epigenome, transcriptome, and proteome
  activity, the metabolome can be considered as being the most proximal correlate
  to the phenotype. ...'
---
 <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Background</h3> <p class="a-plus-plus">Through the systematic large-scale profiling of metabolites, metabolomics provides a tool for biomarker discovery and improving disease monitoring, diagnosis, prognosis, and treatment response, as well as for delineating disease mechanisms and etiology. As a downstream product of the genome and epigenome, transcriptome, and proteome activity, the metabolome can be considered as being the most proximal correlate to the phenotype. ...